Triple-negative breast cancer (TNBC), characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), accounts for 10–15% of all breast cancers. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.